Nephrology
Prevalence and risk factors for Cisplatin nephrotoxicity in adult cancer in-patients in a tertiary hospital
Cisplatin is an antineoplastic drug commonly used in cancer therapy. Nephrotoxocity is one of its limiting side effects and occurs in about 28% of patients who receive the drug. This study aims to determine the prevalence of cisplatin-induced nephrotoxicity and its associated risk factors among adult cancer patients in a tertiary hospital.
A retrospective study on the association between pre-dialysis chronic kidney disease and coronary artery calcification among patients at St Luke's Medical Center
Cardiovascular disease causes a significant morbidity and mortality in patients with chronic kidney disease and coronary artery calcification causes the atherosclerosis. This study examined the association of pre-dialysis chronic kidney disease with coronary artery calcification score.
A case of a 25-year old male presenting with incidental finding of elevated creatinine, microscopic hematuria and proteinuria
IgA nephropathy (IgAN) is classically characterized by episodic hematuria associated with deposition of IgA in the mesangium conincident with mucosal infection. The diagnostic hallmark is seen through renal biopsy showing predominance of IgA deposits either alone or with IgG or IgM
Comparison of Cleveland Clinic Score, Simplified Renal Index (SRI), and Mehta Tool in Predicting Renal Replacement Therapy after Cardiac Surgery
An important risk factor for adverse outcome after cardiac surgery is the development of cardiac surgery related acute kidney injury (CS-AKI), as evidenced by a reduction in glomerular filtration rate (GFR).
Comparison of Tziakas Risk Score vs. Mehran Risk Stratification in predicting contrast-Induced acute kidney injury among patients undergoing coronary angiography or percutaneous coronary intervention at St. Luke’s Medical Center – Quezon City
Contrast-induced acute kidney injury (CI-AKI) occurs after the administration of iodinated contrast media and has become one of the leading causes of hospital acquired acute kidney injury. Clinical risk prediction scoring systems for developing CI-AKI have been developed to stratify the risk of patients undergoing PCI.
The Kidney Disease Improving Global Outcome (KDIGO) in comparison with Risk, Injury, Failure, Loss and End Stage (RIFLE) Criteria as a predictor of clinical outcomes among critically ill patients with acute kidney injury
Acute kidney injury (AKI) is a major clinical complication in the hospital setting particularly in the intensive care unit. Staging of AKI is as important as the diagnosis since it can predict the need for renal replacement therapy (RRT).
A comparison of three prediction models for acute kidney injury requiring renal replacement therapy after coronary artery bypass graft surgery at St. Luke’s Medical Center, QC
Acute kidney injury (AKI) following cardiac surgery is associated with increased post- operative morbidity and mortality. Scoring systems to predict acute kidney injury requiring renal replacement therapy (RRT) among patients undergoing cardiac surgery have been developed to assess risk pre-operatively and assist clinicians on the management post-operatively.
A retrospective study on the association between pre-dialysis chronic kidney disease and coronary artery calcification among patients at St Luke's Medical Center
Cardiovascular disease causes a significant morbidity and mortality in patients with chronic kidney disease and coronary artery calcification causes the atherosclerosis. This study examined the association of pre-dialysis chronic kidney disease with coronary artery calcification score.
Prevalence and risk factors for Cisplatin nephrotoxicity in adult cancer in-patients in a tertiary hospital
Cisplatin is an antineoplastic drug commonly used in cancer therapy. Nephrotoxocity is one of its limiting side effects and occurs in about 28% of patients who receive the drug. This study aims to determine the prevalence of cisplatin-induced nephrotoxicity and its associated risk factors among adult cancer patients in a tertiary hospital.